Home Newsletters Cell Therapy News Comparing the Renoprotective Effects of BM-MSCs versus BM-MSC-Exosomes, When Combined with an...

Comparing the Renoprotective Effects of BM-MSCs versus BM-MSC-Exosomes, When Combined with an Anti-Fibrotic Drug, in Hypertensive Mice

0
Scientists determined whether serelaxin (RLX) could enhance the therapeutic efficacy of bone-marrow-derived- mesecnymal stem cell-exosomes (BM-MSC-EXO), and compared the renoprotective effects of RLX and BM-MSC-EXO versus RLX and BM-MSCs in mice with hypertensive CKD.
[Biomedicine & Pharmacotherapy]

Sorry, but the selected Zotpress account can't be found.

Full ArticleGraphical Abstract
Exit mobile version